Higher plasma levels of F₂-isoprostanes are associated with slower psychomotor speed in healthy older adults

References

• Hedden T, Gabrieli JDE. Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci. 2004;5(2):87–96.
   PubMed Web of Science ®Google Scholar
• Simen AA, Bordner KA, Martin MP, et al. Cognitive dysfunction with aging and the role of inflammation. Ther Adv Chronic Dis. 2011;2(3):175–195.
   PubMedGoogle Scholar
• Harman D. Free radical theory of aging. Mutat Res DNAging. 1992;275(3–6):257–266.
   PubMed Web of Science ®Google Scholar
• Insel KC, Moore IM, Vidrine AN, et al. Biomarkers for cognitive aging part II: oxidative stress, cognitive assessments, and medication adherence. Biol Res Nurs. 2012;14(2):133–138.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59(5):1609–1623.
   PubMed Web of Science ®Google Scholar
• Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 1996;36:83–106.
   PubMed Web of Science ®Google Scholar
• Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005;10(1):S10–S23.
   PubMedGoogle Scholar
• Milne GL, Dai Q, Roberts LJ, II. The isoprostanes −25 years later. Biochim Biophys Acta. 2015;1851(4):433–445.
   PubMed Web of Science ®Google Scholar
• Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38(6):698–710.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004;18(15):1791–1800.
   PubMed Web of Science ®Google Scholar
• Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta. 2014;1840(2):809–817.
   PubMed Web of Science ®Google Scholar
• Fiocco AJ, Kanaya AM, Lindquist KM, et al. Plasma F2-isoprostane level and cognitive function over eight years in non-demented older adults: findings from the Health ABC Study. Prostaglandins Leukot Essent Fatty Acids. 2011;84(1–2):57–61.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Touyz RM, Zweier JL, et al. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association. Circ Res. 2016;119(5):e39–ee75.
   PubMed Web of Science ®Google Scholar
• Sampson MJ, Gopaul N, Davies IR, et al. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diab Care. 2002;25(3):537–541.
   PubMed Web of Science ®Google Scholar
• Praticò D, Iuliano L, Mauriello A, et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 1997;100(8):2028–2034.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Montine KS, McMahan W, et al. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal. 2005;7(1–2):269–275.
   PubMed Web of Science ®Google Scholar
• Steenkamp LR, Hough CM, Reus VI, et al. Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder. J Affect Disord. 2017;219:193–200.
   PubMed Web of Science ®Google Scholar
• Praticò D, Clark CM, Liun F, et al. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol. 2002;59(6):972–976.
   PubMedGoogle Scholar
• Morrow JD, Hill KE, Burk RF, et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87(23):9383–9387.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Peskind ER, Quinn JF, et al. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer’s disease as identified by biomarkers. Neuromolecular Med. 2011;13(1):37–43.
   PubMed Web of Science ®Google Scholar
• Guest J, Grant R, Mori TA, et al. Changes in oxidative damage, inflammation and [NAD(H)] with age in cerebrospinal fluid. PLoS One. 2014;9(1):e85335.
   PubMed Web of Science ®Google Scholar
• Polidori MC, Praticó D, Mangialasche F, et al. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J Alzheimers Dis. 2009;17(4):921–927.
   PubMed Web of Science ®Google Scholar
• Ryan J, Croft K, Mori T, et al. An examination of the effects of the antioxidant pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. J Psychopharmacol. 2008;22(5):553–562.
   PubMed Web of Science ®Google Scholar
• Li G, Millard SP, Peskind ER, et al. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol. 2014;71(6):742–751.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
   PubMed Web of Science ®Google Scholar
• O’Bryant SE, Humphreys JD, Smith GE, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65(7):963–967.
   PubMed Web of Science ®Google Scholar
• Salthouse, TA. Speed of behavior and its implications for cognition. In: Birren JE, Schaie KW. editors. The handbooks of aging. Handbook of the psychology of aging. New York, NY, US: Van Nostrand Reinhold Co.; 1985. p. 400–426.
   Google Scholar
• Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev. 1996;103(3):403–428.
   PubMed Web of Science ®Google Scholar
• Salthouse TA. Aging and measures of processing speed. Biol Psychol. 2000;54(1–3):35–54.
   PubMed Web of Science ®Google Scholar
• Jensen AR. Reaction time and psychometric g. In: Eysenck HJ, editor. A Model for Intelligence. Berlin: Springer; 1982, p. 93–132.
   Google Scholar
• Jensen AR. The theory of intelligence and its measurement. Intelligence. 2011;39(4):171–177.
   Web of Science ®Google Scholar
• Bates T, Stough C. Improved reaction time method, information processing speed, and intelligence. Intelligence. 1998;26(1):53–62.
   Web of Science ®Google Scholar
• Jensen AR. Individual differences in the Hick paradigm. In: Vernon PA, editor. Speed of Information-Processing and intelligence. Westport, CT, US: Ablex Publishing; 1987. p. 101–175.
   Google Scholar
• Buckhalt JA, Reeve TG, Dornier LA. Correlations of movement time and intelligence: effects of simplifying response requirements. Intelligence. 1990;14(4):481–491.
   Web of Science ®Google Scholar
• Houx PJ, Jolles J. Age-related decline of psychomotor speed: effects of age, brain health, sex, and education. Percept Mot Skills. 1993;76(1):195–211.
   PubMed Web of Science ®Google Scholar
• Era P, Sainio P, Koskinen S, et al. Psychomotor speed in a random sample of 7979 subjects aged 30 years and over. Aging Clin Exp Res. 2011;23(2):135–144.
   PubMed Web of Science ®Google Scholar
• Sleimen-Malkoun R, Temprado JJ, Berton E. Age-related dedifferentiation of cognitive and motor slowing: insight from the comparison of Hick-Hyman and Fitts’ laws. Front Aging Neurosci. 2013;5:62.
   PubMed Web of Science ®Google Scholar
• Ward NS, Frackowiak RSJ. Age-related changes in the neural correlates of motor performance. Brain. 2003;126(4):873–888.
   PubMedGoogle Scholar
• Eckert MA. Slowing down: age-related neurobiological predictors of processing speed. Front Neurosci. 2011;5:25.
   PubMed Web of Science ®Google Scholar
• Stough CK, Pase MP, Cropley V, et al. A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910). Nutr J. 2012;11(1)
   Google Scholar
• Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: Psychological Corporation; 1999.
   Google Scholar
• Canivez GL, Konold TR, Collins JM, et al. Construct validity of the Wechsler Abbreviated Scale of Intelligence and Wide Range intelligence test: convergent and structural validity. Sch Psychol Q. 2009;24(4):252–265.
   Web of Science ®Google Scholar
• Mori TA, Croft KD, Puddey IB, et al. An improved method for the measurement of urinary and plasma F2− isoprostanes using gas chromatography-mass spectrometry. Anal Biochem. 1999;268(1):117–125.
   PubMed Web of Science ®Google Scholar
• Proudfoot J, Barden A, Mori TA, et al. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem. 1999;272(2):209–215.
   PubMed Web of Science ®Google Scholar
• Nitschke MF, Arp T, Stavrou G, et al. The cerebellum in the cerebro-cerebellar network for the control of eye and hand movements – an fMRI study. Prog Brain Res. 2005;148:151–164.
   PubMed Web of Science ®Google Scholar
• Andersen BB, Gundersen HJG, Pakkenberg B. Aging of the human cerebellum: a Stereological Study. J Comp Neurol. 2003;466(3):356–365.
   PubMed Web of Science ®Google Scholar
• Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet. 2000;25(3):294–297.
   PubMed Web of Science ®Google Scholar
• Cui L, Hofer T, Rani A, et al. Comparison of lifelong and late life exercise on oxidative stress in the cerebellum. Neurobiol Aging. 2009;30(6):903–909.
   PubMed Web of Science ®Google Scholar
• Forster MJ, Dubey A, Dawson K M, et al. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proceedings of the National Academy of Sciences. 1996;93:4765–4769.
   Google Scholar
• Hu J, Qian J, Borisov O, et al. Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine–specific isobaric tags. Proteomics. 2006;6:4321–4334.
   Google Scholar
• Shukitt-Hale B. The effects of aging and oxidative stress on psychomotor and cognitive behavior. AGE. 1999;22:9–17.
   Google Scholar
• Dorszewska J, Adamczewska-Goncerzewicz Z. Oxidative damage to DNA, p53 gene expression and p53 protein level in the process of aging in rat brain. Respir Physiol Neurobiol. 2004;139(3):227–236.
   PubMed Web of Science ®Google Scholar
• Barja G. Free radicals and aging. Trends Neurosci. 2004;27(10):595–600.
   PubMed Web of Science ®Google Scholar
• Grimaldi P, Rossi F. Lack of neurogenesis in the adult rat cerebellum after Purkinje cell degeneration and growth factor infusion. Eur J Neurosci. 2006;23(10):2657–2668.
   PubMed Web of Science ®Google Scholar
• Comporti M, Signorini C, Arezzini B, et al. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med. 2008;44(3):247–256.
   PubMed Web of Science ®Google Scholar
• Hoffman SW, Moore S, Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 1997;28(4):844–849.
   PubMed Web of Science ®Google Scholar
• Baierle M, Nascimento SN, Moro AM, et al. Relationship between inflammation and oxidative stress and cognitive decline in the institutionalized elderly. Oxid Med Cell Longev. 2015;2015:804198.
   PubMedGoogle Scholar
• Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147(1):S232–SS240.
   PubMedGoogle Scholar
• Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nat Protoc. 2006;1(5):2277–2281.
   PubMed Web of Science ®Google Scholar
• Sánchez-Cubillo I, Periáñez JA, Adrover-Roig D, et al. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009;15(3):438–450.
   Web of Science ®Google Scholar
• Deary IJ, Der G. Reaction time, age, and cognitive ability: longitudinal findings from age 16 to 63 years in representative population samples. Aging Neuropsychol Cogn. 2005;12(2):187–215.
   Web of Science ®Google Scholar
• Galano JM, Mas E, Barden A, et al. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans. Prostaglandins Other Lipid Mediat. 2013;107:95–102.
   PubMed Web of Science ®Google Scholar